0.7858
Assertio Holdings Inc stock is traded at $0.7858, with a volume of 97,290.
It is up +2.05% in the last 24 hours and up +8.67% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
See More
Previous Close:
$0.77
Open:
$0.76
24h Volume:
97,290
Relative Volume:
0.41
Market Cap:
$75.63M
Revenue:
$169.43M
Net Income/Loss:
$-186.01M
P/E Ratio:
-0.389
EPS:
-2.02
Net Cash Flow:
$70.07M
1W Performance:
-3.36%
1M Performance:
+8.67%
6M Performance:
-3.32%
1Y Performance:
-36.63%
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ASRT
Assertio Holdings Inc
|
0.7858 | 78.04M | 169.43M | -186.01M | 70.07M | -2.02 |
![]()
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-26-24 | Initiated | Maxim Group | Buy |
Jul-03-24 | Initiated | H.C. Wainwright | Buy |
Nov-07-22 | Initiated | Lake Street | Buy |
Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
RSI + MACD Show Convergence for Assertio Holdings Inc.2025 AllTime Highs & Consistent Growth Stock Picks - newsyoung.net
What technical models suggest about Assertio Holdings Inc.’s comeback2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
What indicators show strength in Assertio Holdings Inc.Recession Risk & Precise Buy Zone Tips - Newser
RSI and MACD Indicate Shift in Assertio Holdings Inc. SentimentJuly 2025 Intraday Action & Low Risk Entry Point Tips - beatles.ru
Tools to monitor Assertio Holdings Inc. recovery probabilityJuly 2025 Decliners & Fast Exit Strategy with Risk Control - Newser
Is Assertio Holdings Inc. part of any major index2025 Market Overview & AI Powered Market Entry Ideas - thegnnews.com
Assertio Holdings Inc. stock outlook for YEARRate Hike & Precise Swing Trade Entry Alerts - Newser
Is Assertio Holdings Inc. still worth holding after the dipPortfolio Value Report & Safe Swing Trade Setups - Newser
Should you wait for a breakout in Assertio Holdings Inc.Trade Entry Report & Real-Time Stock Movement Alerts - Newser
What makes Assertio Holdings Inc. stock price move sharplyTrade Entry Report & Weekly Momentum Picks - Newser
Is Assertio Holdings Inc. forming a double bottomJuly 2025 Momentum & Verified Momentum Stock Ideas - newsyoung.net
Has Assertio Holdings Inc. formed a bullish divergenceMarket Trend Review & Accurate Trade Setup Notifications - Newser
Assertio Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 5, 2024 to Discuss Your RightsASRT - ACCESS Newswire
Combining machine learning predictions for Assertio Holdings Inc.Bond Market & Real-Time Stock Movement Alerts - Newser
Top chart patterns to watch in Assertio Holdings Inc.Quarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
Assertio Holdings, Inc. (NASDAQ:ASRT) Q2 2025 Earnings Call Transcript - MSN
Assertio narrows 2025 sales guidance to $108M–$118M as transformation accelerates - MSN
Can Assertio Holdings Inc. rally from current levelsCEO Change & Weekly Momentum Picks - Newser
Assertio Holdings Q2 2025 Earnings: Revenue Beats $28.8M, EPS Misses $0.17 Loss - AInvest
Assertio's Price Target Lowered to $3 by H.C. Wainwright - AInvest
NASDAQ: SPPI INVESTOR ALERT: Berger Montague Advises Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors of September 24, 2025 Deadline - cnhinews.com
ASRT’s Stochastic Averages Dip: Analyzing Assertio Holdings Inc’s Stock Performance - investchronicle.com
Is Assertio Holdings Inc. stock poised for growthGap Up & Weekly Setup with High ROI Potential - Newser
Real time social sentiment graph for Assertio Holdings Inc.Breakout Watch & Low Drawdown Momentum Ideas - Newser
Assertio (NASDAQ:ASRT) Given New $3.00 Price Target at HC Wainwright - Defense World
Using Bollinger Bands to evaluate Assertio Holdings Inc. [Weekly Profit Recap]Momentum Based Trading Signals - Newser
Assertio Holdings: HC Wainwright maintains Buy, lowers PT to $3 from $3.5. - AInvest
Assertio Holdings 2025 Q2 Earnings Worse Losses Amid Revenue Decline - AInvest
What momentum shifts mean for Assertio Holdings Inc.Free Reversal Alert Based on RSI Indicator - Newser
Assertio: Q2 Earnings Snapshot - Norwalk Hour
Assertio Holdings Inc (ASRT) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
How high can Assertio Holdings Inc. stock goSafe Investment Ideas with Growth Upside - Newser
Is it time to cut losses on Assertio Holdings Inc.Reversal Pattern Insights with Entry Tips - Newser
Can technical indicators confirm Assertio Holdings Inc.’s reversalValue Holding Return Summary With Outlook - Newser
Assertio (ASRT) Reports Q2 Loss, Beats Revenue Estimates - sharewise.com
Assertio Holdings Q2 2025: Examining Contradictions in Rolvedon and Sympazan Sales Dynamics - AInvest
Transcript : Assertio Holdings, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
Assertio Holdings Outpaces Expectations Despite Flat Sales And Losses - Finimize
Earnings call transcript: Assertio Therapeutics Q2 2025 beats EPS forecast By Investing.com - Investing.com Nigeria
Earnings call transcript: Assertio Therapeutics Q2 2025 beats EPS forecast - Investing.com India
Assertio Holdings Q2 Revenue, Adjusted Profit Exceed Estimates - AInvest
Assertio : Second Quarter 2025 Earnings Release - MarketScreener
Assertio Holdings rises on revenue, adjusted profit beat (ASRT) - Seeking Alpha
Assertio Reports Second Quarter 2025 Financial Results - MarketScreener
Why Assertio Holdings Inc. stock attracts strong analyst attentionEntry and Exit Strategy for Swing Traders - Newser
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Assertio Holdings Inc Stock (ASRT) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Schlessinger Sam | EVP, General Counsel |
May 12 '25 |
Option Exercise |
0.00 |
38,017 |
0 |
191,906 |
Schwichtenberg Paul | See Remarks |
May 12 '25 |
Option Exercise |
0.00 |
38,017 |
0 |
184,362 |
Patel Ajay | EVP and CFO |
May 12 '25 |
Option Exercise |
0.00 |
38,017 |
0 |
213,692 |
Schlessinger Sam | SVP, General Counsel |
Feb 21 '25 |
Option Exercise |
0.00 |
17,150 |
0 |
161,545 |
Schwichtenberg Paul | See Remarks |
Feb 21 '25 |
Option Exercise |
0.00 |
17,150 |
0 |
154,850 |
Patel Ajay | SVP and CFO |
Feb 21 '25 |
Option Exercise |
0.00 |
17,150 |
0 |
184,180 |
Schlessinger Sam | SVP, General Counsel |
Feb 07 '25 |
Option Exercise |
0.00 |
21 |
0 |
153,698 |
Schwichtenberg Paul | See Remarks |
Feb 07 '25 |
Option Exercise |
0.00 |
25,000 |
0 |
150,101 |
Patel Ajay | SVP and CFO |
Feb 07 '25 |
Option Exercise |
0.00 |
25,000 |
0 |
179,431 |
Mason Heather L | Director |
Nov 18 '24 |
Buy |
0.80 |
75,000 |
60,000 |
287,650 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):